JDRF Canada welcomes Senate report on "Breaking Down Barriers" for Canadians with Disabilities in accessing the Disability Tax Credit and Registered Disability Savings Plan
JDRF Canada welcomes a report released today by the Senate Standing Committee on Social Affairs, Science and Technology entitled: “Breaking Down...Read More
JDRF Canada applauds BC government's decision to provide insulin pumps to people of all ages who live with type 1 diabetes
JDRF Canada applauds the British Columbia government’s announcement today extending the province’s current insulin pump program to all ages.
Sun Life Financial grows efforts to fight type 1 diabetes in Canada with title sponsorship of the JDRF Walk to Cure Diabetes
Sponsorship supports growth of type 1 diabetes research and awareness, building upon Sun Life Financial’s $22 million global investment to date
JDRF and our T1D Heroes feel that Manitoba should follow the lead of Alberta, Ontario, Nunavut, North West Territories, and Yukon – provinces and territories which already cover insulin pump costs for all residents.
Ford Motor Company and JDRF Canada are pleased to announce that Ford Windsor Operations has raised a cumulative total of over $1 million for the JDRF TELUS Walk to Cure Diabetes.
The JDRF Revolution Ride challenges Canadians to go further and raise funds to defeat type 1 diabetes.
Eli Lilly Canada Inc. (Lilly Canada) and JDRF Canada have awarded two promising researchers each with a post-doctoral fellowship grant to pursue studies in type 1 diabetes.
JDRF has awarded Dr. James Johnson and his team from the University of British Columbia (UBC) a grant of US$150,000 for a one-year study on whether insulin levels produced by transplanted pancreatic beta cells can be controlled and stabilized.
JDRF and Lilly Canada fund UHN research on new stem cell therapies aimed at eliminating the need for insulin injections.
JDRF and the University of Toronto support research into a skin patch to prevent common, life-threatening risk of T1D
TORONTO – October 20, 2016, JDRF and the University of Toronto are pleased to announce a $400,000 (USD) research grant to support the development of a skin [transdermal] patch to prevent hypoglycemia – a common, potentially life-threatening, risk for people living with type 1 diabet...